EPLUS INC
For the period ended Mar 31, 2024. Filed May 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 23, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ePlus inc.
/s/ MARK P. MARRON
By: Mark P. Marron
Chief Executive Officer and President
Date: May 22, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
/s/ MARK P. MARRON
By: Mark P. Marron
Chief Executive Officer, President, and Director
(Principal Executive Officer)
Date: May 22, 2024
/s/ ELAINE D. MARION
By: Elaine D. Marion, Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: May 22, 2024
/s/ RENEE BERGERON
By: Renée Bergeron, Director
Date: May 22, 2024
/s/ BRUCE M. BOWEN
By: Bruce M. Bowen, Director
Date: May 22, 2024
/s/ JOHN E. CALLIES
By: John E. Callies, Director
Date: May 22, 2024
/s/ C. THOMAS FAULDERS, III
By: C. Thomas Faulders, III, Chairman
Date: May 22, 2024
/s/ IRA A. HUNT
By: Ira A. Hunt, Director
Date: May 22, 2024
/s/ MAUREEN F. MORRISON
By: Maureen F. Morrison, Director
Date: May 22, 2024
/s/ BEN XIANG
By: Ben Xiang, Director
Date: May 22, 2024
INDEX TO FINANCIAL STATEMENTS AND SCHEDULES
| PAGE | |
| Report of Independent Registered Public Accounting Firm Deloitte & Touche LLP (PCAOB ID 34) | F-2 |
|---|---|
| Consolidated Balance Sheets as of March 31, 2024, and 2023 | F-5 |
| Consolidated Statements of Operations for the years ended March 31, 2024, 2023 and 2022 | F-6 |
| Consolidated Statements of Comprehensive Income for the years ended March 31, 2024, 2023 and 2022 | F-7 |
| Consolidated Statements of Cash Flows for the years ended March 31, 2024, 2023 and 2022 | F-8 |
| Consolidated Statements of Stockholders’ Equity for the years ended March 31, 2024, 2023 and 2022 | F-10 |
| Notes to Consolidated Financial Statements | F-11 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.